Trump’s Top Environmental Adviser Says Pesticides Aren’t Bad for You

In addition to not believing in climate change, Myron Ebell has several other lovely qualities.

Like pesticides? Trump's got the right man for you. Dave Martin/AP Photo

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


To lead the transition of the Environmental Protection Agency, President-elect Donald Trump settled on notorious climate change denier Myron Ebell. The decision rattled climate activists—see Julia Lurie’s interview with Bill McKibben and David Roberts and Brad Plumer on Vox. But it isn’t just greenhouse gas emissions that are likely to get a free ride under an Ebell-influenced EPA. Farm chemicals, too, would likely flow unabated if Ebell’s agenda comes to dominate Trump’s EPA.

Ebell’s group dismisses the well-established existence of endocrine-disrupting chemicals as a myth conjured by “anti-chemical activists.”

Ebell directs the Center for Energy and Environment at the Competitive Enterprise Institute. The group runs a  website, SafeChemicalPolicy.org, that exists to downplay the health and ecological impacts of chemicals.

If the incoming EPA takes its cues from Ebell’s group, the agency’s coming decisions on some widely used farm chemicals won’t be hard to predict.

Take the class of pesticides called neonicotinoids. An ever-accumulating weight of evidence links declining honeybee health with neonicotinoids, which have exploded in use since the late 1990s. Yet CEI completely denies any harm to bees from the chemicals and rejects any role for government action in protecting bees.

The EPA has been in the middle of a long, slow review of the chemicals, produced by pesticide giants Syngenta and Bayer. In January 2016, the agency released its assessment of the most prominent one, Bayer’s imidacloprid, which is heavily used on cotton and soybean fields. The result: EPA scientists found the chemical so harmful to bee colonies, at the levels commonly found in cotton fields, that the agency “could potentially take action” to “restrict or limit the use” of the chemical by the end of this year, an agency spokesperson told me in an emailed statement. So far, the EPA has not taken such an action.

As for soybeans, a massive user of imidacloprid, the EPA simply lacked the data from Bayer and independent researchers to assess it—even though the pesticide has been approved for use since the 1990s.

The agency is committed to releasing a slew of other neonic assessments in 2017—and intervening to restrict their use if they harm honeybees. If the Competitive Enterprise Institute’s view of things holds sway, expect very little, if any, action to come of this effort.

Then there’s atrazine, perhaps the most controversial pesticide that’s used widely on US farm fields. Banned in Europe, it’s an endocrine disrupter, a term used for chemicals that mimic hormones and “produce adverse developmental, reproductive, neurological, and immune effects in both humans and wildlife,” according to the National Institute of Environmental Health Sciences.

Widely found in streams and drinking water near farms where it’s used, atrazine triggers sex changes in frogs at extremely low levels, according to research from University of California-Berkeley scientist Tyrone Hayes—work that has earned Hayes a long harassment campaign from the chemical’s maker, Syngenta.

Again, the EPA is in the middle of a slow, grinding reassessment of whether or not to restrict atrazine use. Don’t expect much from a CEI-influenced EPA. SafeChemicalPolicy.com’s atrazine page pitches it as a chemical with “low” risks and “high” rewards, and attacks Hayes. Another page dismisses the well-established existence of endocrine-disrupting chemicals as a myth conjured by “anti-chemical activists.”

So, Ebell’s group doesn’t just brazenly trash established science when it comes to climate change, to the delight of the fossil fuel industry. CEI provides the same service for the companies that dominate agrichemical production. And it’s not hard to see why. The center does not reveal its funding sources, but back in 2013, it allowed a Washington Post reporter to have a look at the biggest donors to its annual gala dinner that year. Predictably, the group got a nice cash infusion from petroleum, coal, and auto interests. But Big Ag chipped in, too: Pesticide/seed giants Monsanto and Syngenta each gave $10,000, as did their trade group, the Biotechnology Industry Organization.

President-elect Trump has been roundly mocked for running as a crusading reformer and then tapping a bunch of industry lobbyists and apologists like Ebell to lead his transition. Rather than “draining the swamp” in Washington, Trump seems to want to inject it with agrichemicals.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate